BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Moreno-Cubero E, Arco RTSD, Peña-Asensio J, Villalobos ES, Míquel J, Larrubia JR. Is it possible to stop nucleos(t)ide analogue treatment in chronic hepatitis B patients? World J Gastroenterol 2018; 24(17): 1825-1838 [PMID: 29740199 DOI: 10.3748/wjg.v24.i17.1825]
URL: https://www.wjgnet.com/1007-9327/full/v24/i17/1825.htm
Number Citing Articles
1
Urbano Sbarigia, Furaha Kariburyo, Janvi Sah, Jamie Colasurdo, Lin Xie, Eva G. Katz, Shirley Sylvester. Evaluating the Effect of Standard of Care Treatment on Burden of Chronic Hepatitis B: A Retrospective Analysis of the United States Veterans PopulationAdvances in Therapy 2020; 37(3): 1156 doi: 10.1007/s12325-020-01240-1
2
Margarita Papatheodoridi, Tung‐Hung Su, Emilia Hadziyannis, Chun‐Hsun Liao, Αfroditi Orfanidou, Hung‐Chi Yang, Kalliopi Zachou, Chun‐Jen Liu, Anastasia Kourikou, Nikolaos Gatselis, Spilios Manolakopoulos, George Dalekos, Jia‐Horng Kao, Stephanos Hadziyannis, George V. Papatheodoridis. Hepatocellular carcinoma after treatment cessation in non‐cirrhotic HBeAg‐negative chronic hepatitis B: A multicentre cohort studyLiver International 2022; 42(3): 541 doi: 10.1111/liv.15128
3
İlknur Esen Yıldız, İlkay Bahçeci, Tuğba Ilgar, Mehmet Beyazal, Uğur Kostakoğlu, Ayşe Ertürk. Is Liver Biopsy Necessary in Patients with Chronic Hepatitis B with Normal Alanine Aminotransferase Level?Viral Hepatitis Journal 2022; 28(1): 1 doi: 10.4274/vhd.galenos.2021.2021-7-1
4
Yafei Guo, Lingan Wang. Comment on “48-Week Outcome after Cessation of Nucleos(t)ide Analogue Treatment in Chronic Hepatitis B Patient and the Associated Factors with Relapse”Canadian Journal of Gastroenterology and Hepatology 2019; 2019: 1 doi: 10.1155/2019/4927083
5
Ching-Lung Lai, Danny Ka-Ho Wong, Gerald Tsz-Yau Wong, Wai-Kay Seto, James Fung, Man-Fung Yuen. Rebound of HBV DNA after cessation of nucleos/tide analogues in chronic hepatitis B patients with undetectable covalently closed circular DNAJHEP Reports 2020; 2(3): 100112 doi: 10.1016/j.jhepr.2020.100112
6
Mala K. Maini, Alice R. Burton. Restoring, releasing or replacing adaptive immunity in chronic hepatitis BNature Reviews Gastroenterology & Hepatology 2019; 16(11): 662 doi: 10.1038/s41575-019-0196-9
7
Jirayu Kammarabutr, Panupong Mahalapbutr, Hisashi Okumura, Peter Wolschann, Thanyada Rungrotmongkol. Structural dynamics and susceptibility of anti-HIV drugs against HBV reverse transcriptaseJournal of Biomolecular Structure and Dynamics 2021; 39(7): 2502 doi: 10.1080/07391102.2020.1751715